Recent News

• 04.17.2025 - Target Market Determination – Placement Offer
• 04.17.2025 - Target Market Determination – Broker Offer
• 04.10.2025 - Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
• 04.10.2025 - Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Recent Filings

• 04.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.17.2025 - EX-99.1 EX-99.1
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - EX-99.1 EX-99.1
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - EX-99.1 EX-99.1
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - EX-99.1 EX-99.1
• 04.09.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.09.2025 - EX-99.1 EX-99.1